Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Splicing factor 3B subunit 3 (SF3B3) is a core component of the SF3b protein complex, which together with SF3a and U2 small nuclear RNA forms the U2 small nuclear ribonucleoprotein (snRNP) complex. SF3B3 plays essential roles in recognizing branch point sequences during pre-mRNA splicing, anchoring U2 snRNP to pre-mRNA, and facilitating spliceosome assembly and activation. It also participates in the minor U12-type spliceosome, and is a subunit of chromatin-modifying complexes like STAGA and TFTC, linking it to transcription regulation and DNA repair. Dysregulation or mutation of SF3B3 is implicated in cancer and inherited syndromes, and it is a direct target for small-molecule splicing modulators such as E7107
Competitive inhibition of branch point sequence binding in the spliceosome by occupying the BPA-binding pocket (e.g., E7107 modulates splicing by binding SF3b complex, disrupting pre-mRNA substrate recognition)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Splicing factor 3B subunit 3 (SF3B3).